[HTML][HTML] limma powers differential expression analyses for RNA-sequencing and microarray studies

ME Ritchie, B Phipson, DI Wu, Y Hu… - Nucleic acids …, 2015 - academic.oup.com
Abstract limma is an R/Bioconductor software package that provides an integrated solution
for analysing data from gene expression experiments. It contains rich features for handling …

[HTML][HTML] Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across …

A Noori, AM Mezlini, BT Hyman, A Serrano-Pozo… - Neurobiology of …, 2021 - Elsevier
Neurodegenerative disorders such as Alzheimer's disease (AD), Lewy body diseases (LBD),
and the amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD) spectrum are …

Microbiome differential abundance methods produce different results across 38 datasets

JT Nearing, GM Douglas, MG Hayes… - Nature …, 2022 - nature.com
Identifying differentially abundant microbes is a common goal of microbiome studies.
Multiple methods are used interchangeably for this purpose in the literature. Yet, there are …

Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress

E Montaldo, E Lusito, V Bianchessi, N Caronni… - Nature …, 2022 - nature.com
Traditionally viewed as poorly plastic, neutrophils are now recognized as functionally
diverse; however, the extent and determinants of neutrophil heterogeneity in humans remain …

[HTML][HTML] IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression

A Sadik, LFS Patterson, S Öztürk, SR Mohapatra… - Cell, 2020 - cell.com
Aryl hydrocarbon receptor (AHR) activation by tryptophan (Trp) catabolites enhances tumor
malignancy and suppresses anti-tumor immunity. The context specificity of AHR target …

Checkpoint blockade immunotherapy induces dynamic changes in PD-1− CD8+ tumor-infiltrating T cells

S Kurtulus, A Madi, G Escobar, M Klapholz, J Nyman… - Immunity, 2019 - cell.com
An improved understanding of the anti-tumor CD8+ T cell response after checkpoint
blockade would enable more informed and effective therapeutic strategies. Here we …

[HTML][HTML] From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline

Y Chen, ATL Lun, GK Smyth - F1000Research, 2016 - ncbi.nlm.nih.gov
In recent years, RNA sequencing (RNA-seq) has become a very widely used technology for
profiling gene expression. One of the most common aims of RNA-seq profiling is to identify …

Interferon-ε is a tumour suppressor and restricts ovarian cancer

ZRC Marks, NK Campbell, NE Mangan… - Nature, 2023 - nature.com
High-grade serous ovarian cancers have low survival rates because of their late
presentation with extensive peritoneal metastases and frequent chemoresistance, and …

[HTML][HTML] Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer

SA Best, PM Gubser, S Sethumadhavan, A Kersbergen… - Cell Metabolism, 2022 - cell.com
The tumor microenvironment (TME) contains a rich source of nutrients that sustains cell
growth and facilitate tumor development. Glucose and glutamine in the TME are essential for …

[HTML][HTML] The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

SJ Vervoort, SA Welsh, JR Devlin, E Barbieri… - Cell, 2021 - cell.com
Gene expression by RNA polymerase II (RNAPII) is tightly controlled by cyclin-dependent
kinases (CDKs) at discrete checkpoints during the transcription cycle. The pausing …